GURU.Markets stock price, segment price, and overall market index valuation
The company's share price NeuroOne Medical Technologies
NeuroOne develops thin-film electrodes for monitoring and treating neurological diseases. Its stock price is a venture bet that its technology will prove more effective and safer than existing methods.
Share prices of companies in the market segment - Specialized medical equipment
NeuroOne Medical Technologies develops thin-film electrodes for the diagnosis and treatment of neurological disorders such as epilepsy. We've classified it as "Specialized Medical Equipment." The chart below shows how investors rate innovations in neurosurgery.
Broad Market Index - GURU.Markets
NeuroOne Medical Technologies develops thin-film electrodes for the diagnosis and treatment of neurological diseases such as epilepsy. As a component of the GURU.Markets index, it represents the neurosurgical innovation sector. The chart below represents the entire market. See how this company's stock compares to the overall trend.
Change in the price of a company, segment, and market as a whole per day
NMTC - Daily change in the company's share price NeuroOne Medical Technologies
For NeuroOne Medical Technologies, a developer of EEG electrodes, daily volatility reflects sensitivity to FDA approvals and hospital contracts. This metric is an indicator of demand for innovative medical equipment.
Daily change in the price of a set of shares in a market segment - Specialized medical equipment
NeuroOne Medical Technologies Corporation is a company in the medical device sector. This chart illustrates the high volatility of the MedTech industry. Comparing it to NMTC, which focuses on neurosurgery, helps assess the extent to which its innovative products contribute to its volatility.
Daily change in the price of a broad market stock, index - GURU.Markets
NeuroOne develops thin-film electrodes for monitoring and treating neurological diseases. This innovative medtech company's shares are responding to clinical successes and regulatory decisions. Its history reflects the medtech sector's contribution to overall volatility.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization NeuroOne Medical Technologies
NeuroOne Medical Technologies' year-over-year performance tells the story of its innovative neurosurgical electrode development. Its market capitalization growth over the past 12 months reflects its progress in obtaining FDA approval and commercializing its thin-film electrodes, which promise to improve the diagnosis and treatment of epilepsy and other neurological disorders.
Annual dynamics of market capitalization of the market segment - Specialized medical equipment
NeuroOne, a company developing thin-film electrodes for neurology, is betting on medical innovation. Its performance relative to the sector will reveal the extent to which investors believe in its ability to commercialize its unique technology for diagnosing and treating brain diseases.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
NeuroOne, which develops electrodes for neurological procedures, is a speculative bet on the future of medicine. Its stock price is not tied to the economy, but is driven by its technological breakthroughs and partnerships with major players. The chart tells the story of investors' faith that its innovation will become the new standard.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization NeuroOne Medical Technologies
NeuroOne is developing thin-film electrodes for neurological applications. Currently in the commercialization stage, its monthly valuation is dependent on progress toward FDA approval and initial sales. News on clinical data and hospital partnerships are key.
Monthly dynamics of market capitalization of the market segment - Specialized medical equipment
NeuroOne develops thin-film electrodes for the diagnosis and treatment of neurological disorders such as epilepsy. The company's technology promises to be less invasive and more precise. The chart below reflects the current sentiment in the specialized medical equipment sector.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
NeuroOne Medical Technologies creates thin-film electrodes for neurological applications. It is a high-tech medical device company. Its stock price is driven by news of regulatory approvals, clinical data, and partnerships, rather than by overall market sentiment.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization NeuroOne Medical Technologies
NeuroOne Medical Technologies creates thin-film electrodes for neurosurgery. The company's weekly stock price is highly volatile and depends on key events, including FDA approval, clinical results of its technology, and news of partnerships with medical device manufacturers.
Weekly dynamics of market capitalization of the market segment - Specialized medical equipment
NeuroOne Medical Technologies creates thin-film electrodes for neurosurgery. The company's weekly stock price is highly volatile and depends on key events, including FDA approval, clinical results of its technology, and news of partnerships with medical device manufacturers.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Shares of NeuroOne, a medical technology company, live in a world of their own. Their performance is determined by news of regulatory approvals. A chart comparing the stock to the S&P 500 clearly demonstrates how the stock can rise or fall on company-specific events, completely ignoring the market.
Market capitalization of the company, segment and market as a whole
NMTC - Market capitalization of the company NeuroOne Medical Technologies
NeuroOne's market capitalization is a story about the development of innovative thin-film electrodes for neurosurgery. This medical device company's stock price reflects investor hopes that its technology will improve the diagnosis and treatment of epilepsy and other neurological disorders. Its volatility reflects the company's reaction to FDA news and trial data.
NMTC - Share of the company's market capitalization NeuroOne Medical Technologies within the market segment - Specialized medical equipment
NeuroOne Medical Technologies develops thin-film electrodes for the diagnosis and treatment of neurological diseases. Its market share in its niche segment reflects the potential of its innovative technology. The chart below shows how the market assesses its chances of regulatory approval and commercial success.
Market capitalization of the market segment - Specialized medical equipment
NeuroOne develops thin-film electrodes for the diagnosis and treatment of neurological diseases such as epilepsy. The chart below shows the overall market capitalization of the specialized medical equipment sector. It illustrates how new materials and technologies can revolutionize the treatment of complex brain conditions.
Market capitalization of all companies included in a broad market index - GURU.Markets
This chart shows innovations in neurosurgery. NeuroOne develops thin-film electrodes for brain monitoring and stimulation. Its capitalization is a bet that these safer and more effective technologies will become the new standard in the treatment of epilepsy and other neurological disorders.
Book value capitalization of the company, segment and market as a whole
NMTC - Book value capitalization of the company NeuroOne Medical Technologies
NeuroOne's capital consists of its patent portfolio for thin-film electrodes for monitoring and treating neurological diseases, as well as its financial reserves. This represents cutting-edge scientific capital. The chart shows how the company accumulates and expends resources to complete regulatory procedures and bring its innovative medical devices to market.
NMTC - Share of the company's book capitalization NeuroOne Medical Technologies within the market segment - Specialized medical equipment
NeuroOne creates thin-film electrodes for monitoring and treating neurological diseases. Its assets include the manufacturing facilities for creating these high-tech medical devices. The chart shows the company's share of this niche but critical physical infrastructure.
Market segment balance sheet capitalization - Specialized medical equipment
The development of neurosurgical equipment, as the BCap_Seg graph shows, is a capital-intensive and high-tech process. NeuroOne Medical Technologies competes in this environment, which requires significant investment in cleanrooms and precision manufacturing to create its thin-film electrodes.
Book value of all companies included in the broad market index - GURU.Markets
NeuroOne's book value represents the capital invested in the development and production of thin-film electrodes for brain monitoring. It represents the material basis for the creation of high-tech medical devices that give surgeons "eyes" for working with the most complex physical structureβthe brain.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - NeuroOne Medical Technologies
NeuroOne develops thin-film electrodes for neurological surgeries and diagnostics. Its book value is small compared to the potential of its innovative technology. The MvsBCap chart shows the premium for intellectual property. Its dynamics will directly depend on FDA approvals and successful product launches.
Market to book capitalization ratio in a market segment - Specialized medical equipment
NeuroOne Medical Technologies develops thin-film electrodes for neurological research and treatment. The company's value lies in its unique technology and patents. The chart shows how the market perceives its potential to transform the diagnosis and treatment of brain diseases.
Market to book capitalization ratio for the market as a whole
NeuroOne Medical Technologies creates thin-film electrodes for neurological surgeries and diagnostics. It is a high-tech medical product. The company's market valuation reflects not the cost of its production equipment, but the uniqueness of its technology and the potential to capture market share in the specialized medical market.
Debts of the company, segment and market as a whole
NMTC - Company debts NeuroOne Medical Technologies
NeuroOne, a company developing thin-film electrodes for neurological surgeries, is raising funds to conduct clinical trials and obtain regulatory approval. Developing Class III medical devices is a lengthy and expensive process. This chart shows how the company is managing its capital on the path to commercializing its technology.
Market segment debts - Specialized medical equipment
NeuroOne Medical Technologies develops thin-film electrodes for neurological applications, such as the diagnosis and treatment of epilepsy. In the advanced medical device sector, R&D and regulatory approval require significant capital. The chart shows how the company finances its journey from development to commercialization.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio NeuroOne Medical Technologies
NeuroOne Medical develops thin-film electrodes for neurological surgeries. This chart shows how much debt the company is raising to finance its high-tech developments. High debt levels could become critical if commercialization is delayed or competitors offer a cheaper solution.
Market segment debt to market segment book capitalization - Specialized medical equipment
NeuroOne Medical Technologies develops thin-film electrodes for neurological applications, such as epilepsy diagnosis and treatment. The chart illustrates the debt burden in the high-tech medical equipment sector. It helps assess how the company finances its unique developments compared to other players in the neurotechnology market.
Debt to book value of all companies in the market
NeuroOne Medical Technologies creates innovative thin-film electrodes for neurological diagnostics and treatment. The overall debt burden in the economy, as shown by this chart, impacts the budgets of hospitals and research centers. This impacts their ability to purchase advanced medical equipment, which is critical to NeuroOne's growth.
P/E of the company, segment and market as a whole
P/E - NeuroOne Medical Technologies
For NeuroOne Medical Technologies, which creates thin-film electrodes for neurosurgery, this chart shows the market's valuation of its breakthrough technology. The high values ββreflect investors' hopes that its products will improve the diagnosis and treatment of epilepsy and other neurological diseases, filling an important niche.
P/E of the market segment - Specialized medical equipment
This chart shows the average price-to-earnings ratio for the specialized medical equipment sector, where NeuroOne is an innovator. The industry's high valuation reflects faith in new technologies. This metric serves as a benchmark for understanding how disruptive the market perceives NeuroOne's electrode technology compared to other developments in neurosurgery.
P/E of the market as a whole
NeuroOne Medical Technologies develops thin-film electrodes for the diagnosis and treatment of neurological diseases such as epilepsy. This is a cutting-edge technology in neurosurgery. This chart shows sentiment in the medical technology sector. It helps understand whether the market believes in the superiority of NeuroOne's technology and how its valuation is responding to news about clinical applications and regulatory approvals.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company NeuroOne Medical Technologies
NeuroOne Medical Technologies develops thin-film electrodes for the diagnosis and treatment of neurological diseases such as epilepsy. The company's valuation is a bet on its technology. This chart reflects analysts' belief that the company's products will receive regulatory approval and be in demand by neurosurgeons.
Future (projected) P/E of the market segment - Specialized medical equipment
NeuroOne Medical Technologies creates thin-film electrodes for the diagnosis and treatment of neurological disorders such as epilepsy. This chart shows how analysts estimate its future revenue compared to other medical device manufacturers. Does the market believe its technology will provide more precise and safe neurostimulation?
Future (projected) P/E of the market as a whole
NeuroOne Medical Technologies creates thin-film electrodes for neurological research and treatment. As a company at the intersection of medicine and high technology, it relies on funding for innovation. This chart, reflecting overall risk appetite, shows how willing the market is to support capital-intensive developments. Investor optimism is a key driver of NeuroOne's growth.
Profit of the company, segment and market as a whole
Company profit NeuroOne Medical Technologies
NeuroOne Medical Technologies develops thin-film electrodes for the diagnosis and treatment of neurological diseases such as epilepsy. The company's revenue depends on regulatory approval and the implementation of its technology in hospitals. This graph shows the path from R&D costs to potential revenue from commercialization of breakthrough medical devices.
Profit of companies in the market segment - Specialized medical equipment
NeuroOne Medical Technologies develops thin-film electrodes for the diagnosis and treatment of neurological diseases such as epilepsy. This is a high-tech niche in medicine. This graph illustrates the overall dynamics in the specialized medical equipment sector, where breakthrough technologies can significantly improve treatment outcomes and create a new standard of care.
Overall market profit
NeuroOne Medical Technologies creates thin-film electrodes for neurological procedures. Demand for these innovative medical devices depends on hospital funding and their willingness to embrace new technologies. This trend, reflecting the health of the economy, indirectly impacts the availability of capital for healthcare modernization.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company NeuroOne Medical Technologies
NeuroOne Medical Technologies creates thin-film electrodes for the diagnosis and treatment of neurological diseases such as epilepsy. This is an innovation in neurosurgery. This chart reflects the analyst consensus forecast, which is a bet on the commercial success and future profitability of this cutting-edge medical technology.
Future (predicted) profit of companies in the market segment - Specialized medical equipment
NeuroOne Medical Technologies develops thin-film electrodes for the diagnosis and treatment of neurological disorders such as epilepsy. The company's technology is designed to be less invasive and more precise than existing technologies. This chart shows profitability forecasts for the medical device sector, providing context for assessing the potential of breakthrough technologies in neurosurgery.
Future (predicted) profit of the market as a whole
NeuroOne Medical Technologies creates thin-film electrodes for the diagnosis and treatment of neurological diseases. Demand for its products is generated by hospital and research center budgets. This graph, illustrating overall profitability expectations, helps assess the healthcare system's financial capacity to implement advanced medical technologies.
P/S of the company, segment and market as a whole
P/S - NeuroOne Medical Technologies
NeuroOne develops medical technologies for the treatment of neurological diseases. This chart reflects investor confidence in its innovative products. The high valuation for its relatively small revenue suggests that the market is pricing in future success after regulatory approvals.
P/S market segment - Specialized medical equipment
NeuroOne Medical Technologies develops thin-film electrodes for the diagnosis and treatment of neurological diseases such as epilepsy. This chart shows the average revenue estimate for the medical device sector. It helps understand the premium investors are placing on the potential of NeuroOne's innovative technology to improve surgical and diagnostic procedures.
P/S of the market as a whole
NeuroOne Medical Technologies creates thin-film electrodes for the diagnosis and treatment of neurological disorders such as epilepsy. Their technology promises to be less invasive and more precise. This chart, showing company valuations based on actual revenue, serves as a contrast, highlighting investor expectations for breakthrough NMTC medical devices.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company NeuroOne Medical Technologies
NeuroOne Medical Technologies creates thin-film electrodes for the diagnosis and treatment of neurological diseases such as epilepsy. This chart reflects market expectations for this innovative technology. This estimate is based on future sales of its electrodes, which could offer more accurate and less invasive monitoring of brain activity.
Future (projected) P/S of the market segment - Specialized medical equipment
NeuroOne Medical Technologies develops thin-film electrodes for the diagnosis and treatment of neurological disorders such as epilepsy. This cutting-edge technology aims to improve patient outcomes. This chart shows how investors value its innovative products compared to the specialized medical device sector.
Future (projected) P/S of the market as a whole
NeuroOne Medical Technologies creates thin-film electrodes for the diagnosis and treatment of neurological diseases. This chart, reflecting NeuroOne's commitment to investing in medical innovation, is an important backdrop. Economic growth and market optimism are fueling increased budgets for hospitals and research centers, the primary buyers of such advanced technology.
Sales of the company, segment and market as a whole
Company sales NeuroOne Medical Technologies
NeuroOne Medical Technologies develops thin-film electrodes for the diagnosis and treatment of neurological diseases such as epilepsy. This chart shows revenue, which at this stage may consist of grants, partner payments, or limited sales. It reflects progress in commercializing this innovative technology for brain monitoring and stimulation.
Sales of companies in the market segment - Specialized medical equipment
NeuroOne Medical Technologies develops advanced thin-film electrodes for the diagnosis and treatment of neurological diseases such as epilepsy. The company's business can be divided into diagnostic equipment and therapeutic devices. This chart reflects the financial flows associated with one of these high-tech medical areas.
Overall market sales
NeuroOne Medical Technologies creates thin-film electrodes for the diagnosis and treatment of neurological diseases. This innovative technology has the potential to dramatically improve the monitoring and treatment of epilepsy and other conditions. The company's success depends on medical breakthroughs and exemplifies how advanced technology is changing quality of life and creating new markets.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company NeuroOne Medical Technologies
NeuroOne Medical Technologies develops thin-film electrodes for the diagnosis and treatment of neurological disorders such as epilepsy. Future sales projections are based on expectations of regulatory approvals and the adoption of its technology in clinical practice. This is a bet that its electrodes will offer significant advantages over existing technologies.
Future (projected) sales of companies in the market segment - Specialized medical equipment
NeuroOne Medical Technologies creates thin-film electrodes for the diagnosis and treatment of neurological diseases. This chart shows expectations for the specialized medical equipment sector. It helps assess the progress analysts predict in neurosurgery and brain monitoring, which drives the implementation of NeuroOne's innovative technologies.
Future (projected) sales of the market as a whole
NeuroOne Medical Technologies creates thin-film electrodes for neurological procedures. Demand for its innovative products depends on hospital budgets and their willingness to implement new technologies. This chart of overall sales forecasts reflects the state of the economy, which impacts healthcare costs.
Marginality of the company, segment and market as a whole
Company marginality NeuroOne Medical Technologies
NeuroOne Medical Technologies develops thin-film electrodes for the diagnosis and treatment of neurological diseases. As a company in the development and regulatory approval stage, it actively invests in R&D. This chart shows the current ratio of innovation expenditures to revenue, reflecting the path to commercialization of breakthrough medical technologies.
Market segment marginality - Specialized medical equipment
NeuroOne Medical Technologies develops thin-film electrodes for the diagnosis and treatment of neurological diseases. For a manufacturer of highly specialized medical equipment, profitability depends on the uniqueness of the technology and the effectiveness of its commercialization. The chart shows the company's operating model compared to its competitors.
Market marginality as a whole
NeuroOne Medical Technologies creates thin-film electrodes for the diagnosis and treatment of neurological diseases. This innovative technology is designed to improve surgical procedures. This graph reflects the profitability of existing businesses, while NMTC's value is determined by the potential of its technology to become a new standard in neurosurgery.
Employees in the company, segment and market as a whole
Number of employees in the company NeuroOne Medical Technologies
NeuroOne Medical Technologies is developing a new generation of electrodes for the diagnosis and treatment of neurological diseases. This graph shows a compact team of engineers and scientists. For a company developing complex medical devices, the team's growth signifies progress toward regulatory approval and commercial launch.
Share of the company's employees NeuroOne Medical Technologies within the market segment - Specialized medical equipment
NeuroOne Medical Technologies creates thin-film electrodes for the diagnosis and treatment of neurological diseases. The development and production of such high-tech medical devices is a challenge for a team of experts. This chart illustrates the breadth of their expertise in the cutting-edge field of neurotechnology.
Number of employees in the market segment - Specialized medical equipment
NeuroOne Medical Technologies develops thin-film electrodes for the diagnosis and treatment of neurological diseases. This chart shows employment in the specialized medical equipment sector. The growing number of neurosurgeons and engineers in this niche reflects advances in understanding the brain and the need for more precise and less invasive neurosurgical tools.
Number of employees in the market as a whole
NeuroOne Medical Technologies develops thin-film electrodes for neurosurgery. This is a highly specialized sector of MedTech. Its growth is driven not by the general labor market, but by technological innovations and regulatory approvals that open access to a new standard of treatment.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company NeuroOne Medical Technologies (NMTC)
NeuroOne Medical Technologies Corporation creates thin-film electrodes for neurosurgery. Its high market capitalization per employee reflects its position at the forefront of medical technology. This chart demonstrates that investors prioritize the potential of a unique technology and its patents over production capacity.
Market capitalization per employee (in thousands of dollars) in the market segment - Specialized medical equipment
NeuroOne Medical Technologies creates cutting-edge thin-film electrodes for neurological diagnostics and treatment. In the high-tech medical sector, this metric reflects how the market values ββa company's innovative potential and patents per employee. It's an indicator of the value of a team working at the forefront of neurotechnology.
Market capitalization per employee (in thousands of dollars) for the overall market
NeuroOne Medical Technologies creates thin-film electrodes for the diagnosis and treatment of neurological diseases. This is a cutting-edge technology in neurosurgery. This chart reflects the market's appreciation for medical innovations, where a small team of engineers and scientists can radically change treatment approaches.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company NeuroOne Medical Technologies (NMTC)
NeuroOne Medical Technologies develops thin-film electrodes for neurological procedures (EEG, ablation). This is cutting-edge medical technology. This graph likely reflects the R&D stage (negative values), showing how much capital is invested in each engineer and scientist. As commercialization progresses, it will measure how efficiently they can produce and market these high-tech electrodes.
Profit per employee (in thousands of dollars) in the market segment - Specialized medical equipment
NeuroOne Medical Technologies creates thin-film electrodes for the diagnosis and treatment of neurological diseases. In the high-tech medical equipment sector, a team of engineers and clinicians plays a key role. This metric serves as an indicator of their productivity, reflecting how effectively they convert innovation into profit compared to the industry benchmark.
Profit per employee (in thousands of dollars) for the market as a whole
NeuroOne is a company developing innovative thin-film electrodes for neurosurgery and diagnostics. It is a MedTech company at the intersection of R&D and early commercialization. This metric demonstrates the balance between the costs of a team of engineers and scientists seeking FDA approval and the initial revenues, if any, already generated. This is the "cost" of innovation per employee.
Sales to employees of the company, segment and market as a whole
Sales per company employee NeuroOne Medical Technologies (NMTC)
NeuroOne Medical Technologies develops thin-film electrodes for the diagnosis and treatment of neurological diseases. This graph shows the company's path from development to commercialization. Increasing revenue per employee will indicate the successful implementation of its innovative technology into clinical practice.
Sales per employee in the market segment - Specialized medical equipment
NeuroOne Medical Technologies creates innovative thin-film electrodes for monitoring and treating neurological diseases (such as epilepsy). This high-tech medical equipment is used to develop innovative technologies. This graph compares NeuroOne's revenue per employee to the industry average, demonstrating the demand and productivity of their unique R&D product.
Sales per employee for the market as a whole
NeuroOne Medical Technologies develops innovative thin-film electrodes for monitoring and treating neurological diseases (such as epilepsy). This is an R&D business in the MedTech sector. During the pre-commercialization phase, this graph will likely show $0. This will become key once the company begins generating revenue from sales of its high-tech medical devices.
Short shares by company, segment and market as a whole
Shares shorted by company NeuroOne Medical Technologies (NMTC)
NeuroOne Medical (NMTC) develops thin-film electrodes for monitoring and treating epilepsy and other neurological disorders. This is a niche market in medical technology, and the company is in its early stages. This chart shows the number of investors who doubt the technology's commercial potential or fear high cash burn.
Shares shorted by market segment - Specialized medical equipment
NeuroOne Medical Technologies develops thin-film electrodes for brain procedures such as EEG and epilepsy stimulation. This is a niche sector of neurosurgical equipment. This chart shows a collective short squeeze on the neurological medical equipment sector, reflecting investor concerns about the speed with which surgeons will adopt new technologies.
Shares shorted by the overall market
NeuroOne (NMTC) is an R&D company developing EEG electrodes. It's a speculative bet on the "technology of the future." When this market fear indicator rises, investors are unwilling to fund "science." They're selling off "concept stocks" en masse without profit, fearing NMTC will run out of cash.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator NeuroOne Medical Technologies (NMTC)
NeuroOne Medical Technologies develops thin-film electrodes for EEG and brain surgery. It's a high-tech medical product. This chart shows how investors react to news of FDA approvals or hospital partnerships, reflecting "overheated" (above 70) for positive sentiment or "oversold" (below 30) in anticipation of news.
RSI 14 Market Segment - Specialized medical equipment
NeuroOne is a medical company developing thin-film electrodes (sEEG and EEG) for monitoring and diagnosing neurological disorders such as epilepsy. This indicator reflects the overall momentum in the specialized medical equipment sector and helps determine whether the entire segment is overheated by expectations.
RSI 14 for the overall market
For NeuroOne Medical, a biotech company in R&D, this chart is a lifeline showing capital availability. During periods of market euphoria, investors are willing to "buy the dream" and fund breakthrough but risky research. When the market panics, the money supply is turned off, and cash-burning companies face a liquidity crisis.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast NMTC (NeuroOne Medical Technologies)
NeuroOne Medical is a company developing thin-film electrodes (sEEG and ECoG) for monitoring and treating epilepsy and other neurological disorders. This chart shows the analysts' average 12-month forecast, representing their collective bet that their technology will surpass existing standards.
The difference between the consensus estimate and the actual stock price NMTC (NeuroOne Medical Technologies)
NeuroOne is a medical technology company developing flexible and thin-film electrodes (Evo) for neurosurgery (EEG, brain mapping). This chart shows the difference between the market valuation and the consensus forecast. It indicates whether experts believe their technology is superior to existing electrodes.
Analyst consensus forecast for stock prices by market segment - Specialized medical equipment
NeuroOne is a medical company developing next-generation (thin-film) electrodes for neurosurgery. They are used for epilepsy monitoring and brain surgery. This chart shows general expectations for the specialized medical equipment sector. It reflects whether experts believe the high-tech neurosurgery market will grow.
Analysts' consensus forecast for the overall market share price
NeuroOne Medical Technologies is a company developing thin-film electrodes (sEEG) for monitoring and diagnosing neurological disorders such as epilepsy. This chart shows the overall market sentiment. For NeuroOne, a company with innovative medical equipment, overall optimism is important for funding and convincing surgeons to adopt their technology.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index NeuroOne Medical Technologies
NeuroOne Medical is a MedTech company that sees the brain. They develop flexible thin-film electrodes (sEEG and ECoG) for neurosurgery, which allow doctors to more accurately diagnose and treat epilepsy and brain tumors. This graph summarizes their R&D efforts. It reflects their progress toward FDA approval and their ability to compete with rigid electrodes.
AKIMA Market Segment Index - Specialized medical equipment
NeuroOne Medical (NMTC) develops and manufactures thin-film electrodes (Evo) for neurosurgery. They are used to record electrical activity in the brain and for epilepsy ablation. The chart shows the average index for the segment, helping investors assess the demand for this highly specialized technology in neurosurgery compared to the average.
The AKIM Index for the overall market
NeuroOne Medical is a medtech company producing thin-film electrodes for brain recording and stimulation (for epilepsy and neurosurgery). This chart, which reflects the market average, is a backdrop. It helps assess how the NMTC, as it commercializes its products, compares to overall macroeconomic trends.